Tower Research Capital LLC (Trc) Verrica Pharmaceuticals Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,690 shares of VRCA stock, worth $37,285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,690
Previous 1,527
207.14%
Holding current value
$37,285
Previous $9,000
277.78%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding VRCA
# of Institutions
71Shares Held
17.4MCall Options Held
6.1KPut Options Held
6.3K-
Perceptive Advisors LLC New York, NY7.1MShares$56.4 Million1.5% of portfolio
-
Avoro Capital Advisors LLC New York, NY4MShares$31.8 Million0.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.27MShares$10.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.13MShares$8.98 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA463KShares$3.68 Million0.0% of portfolio
About Verrica Pharmaceuticals Inc.
- Ticker VRCA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,094,100
- Market Cap $327M
- Description
- Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...